Linked research, clinical, and regulatory source pathways.
Company profile
About Sevaro
Sevaro is a teleneurology and virtual care company that revolutionizes neurological care delivery through its proprietary Synapse AI platform and comprehensive virtual neurology services. The company provides 24/7 access to board-certified neurologists for hospitals and health systems, delivering care across the full patient journey from acute stroke response to outpatient follow-up. Sevaro's flagship offering includes virtual acute stroke services with sub-45-second response times, virtual neurohospitalist rounding, remote EEG interpretation, neuro-intensive care, neuro-rehabilitation, and ambulatory clinic services. The company's Synapse AI platform integrates advanced artificial intelligence with human clinical expertise to enable seamless collaboration between in-house neurology teams and virtual specialists. With over 1 million clinical interactions powered through their platform, Sevaro serves hospitals across the United States, helping reduce patient transfers and length of stay while improving access to specialized neurological care. The company has achieved Joint Commission Ambulatory Health Care Accreditation and SOC2 compliance, demonstrating commitment to quality and data security. Sevaro's technology includes Nirvana Notes, an AI-powered touchless documentation system, and Premium Analytics for data-driven insights. The company also operates patient education initiatives including the 'My Stroke Journey' program and nationwide stroke awareness campaigns targeting children and families.
Company description Sevaro official website
Primary marketTelemedicine & Virtual Care
Commercial modelCommercial information available on request
Company presenceOfficial website
Work at Sevaro?
Claim this listing Claim this profile to manage Company information and connect with the Health AI Central audience.
01 · Operating footprint
Where the Company operates
Company-profile context for clinical focus, customers, deployment, integration, milestones, and partnerships.
Clinical focus
- Acute neurology
- Epilepsy/EEG
- General neurology
- Neuro-intensive care
- Neuro-rehabilitation
- Stroke
Who it serves
- Emergency Departments
- Health Systems
- Hospitals
- ICUs
Deployment & integration
Deployment information is currently being developed.
Geographic context
MarketsUnited States
Company sourceOfficial website
Company milestones
Platform expansion
Secured $39M funding, named to CB Insights 2025 list of 50 Most Promising Digital Health Startups, launched Synapse AI with Nirvana Notes touchless documentation, achieved Joint Commission accreditation and SOC2 compliance, launched nationwide stroke awareness campaign
Partnerships
Recorded partners
- Montana Hospital Association (preferred stroke care provider)
- NSCAC (National Stroke Care Alliance Coalition)
- Yale School of Medicine (stroke awareness education)
02 · Flagship portfolio
Products, workflows, and platform capabilities
Selected source-backed Company products and the available commercial context.
No source-backed Company products are currently listed.
03 · Research intelligence
Research Intelligence evidence
Publications, preprints, clinical validation, and regulatory records in Evidence Position order.
Evidence position
Publications, clinical validation, and regulatory records connected to this Company appear here.
Research
Publications & preprints
Pregnancy outcomes and changes to seizure frequency during pregnancy for patients with functional seizures.Epilepsy & behavior : E&B · Oct 1, 2025
Clinical validation
Clinical-trial records
No linked records are currently available.
Regulatory
Regulatory records
No linked records are currently available.
04 · Company-reported outcomes
Outcomes and case studies
Company-reported outcomes and customer stories are distinct from linked Research Intelligence evidence.
Response time
Less than 45 second response time for telestroke consultations
Patient transfers
Reduction in patient transfers (percentage not specified)
Length of stay
Reduction in length of stay (percentage not specified)
Clinical interactions
Over 1 million clinical interactions powered
Time to consult
Reduced from 20 minutes average to sub-45 seconds
05 · Leadership
Leadership team
Leadership profiles and professional links from the current Company record.
No active leadership profiles are currently listed.
06 · Company updates
Updates from Sevaro
Recent articles published on Sevaro's official website.
How Virtual Outpatient Neuro-Rehab Ensures Continuity After Hospital Discharge
Read on SevaroNIHSS 23 to Zero: How Sevaro’s Telestroke Partnership Enabled Complete Neurological Recovery in 4 Days
Read on SevaroReducing Interfacility Transfers for Stroke Patients Through Virtual Neurology
Read on SevaroTele-Stroke Neurologist: Full-Time
Read on SevaroHow a 5-Year-Old is Helping Save Lives: New Book by Telestroke CEO & Son Teaches Kids to Spot Stroke Signs
Read on Sevaro07 · HAIC coverage
Coverage and analysis
Health AI Central reporting that mentions this Company.
No HAIC coverage is currently linked to this Company.
08 · Official presence
Company sources and channels
Curated official destinations from the active Company record.
09 · Market pathway
Additional Companies in this Market
Other active Companies in the same market, selected alphabetically from the HAIC directory.
Market context
Telemedicine & Virtual Care
Companies providing AI-enhanced telemedicine platforms, virtual care delivery systems, AI-powered triage, or virtual health assistants that facilitate remote clinical consultations between patients and healthcare providers. Includes integrated telehealth platforms with AI capabilities for scheduling, triage, and follow-up care.
Explore the full market directory or compare this Company with additional active profiles.
View all Companies in this market10 · Pro research
Coming soon
Expanded Company research is in development.
Health AI Central Pro · Coming Soon
Deeper Company research is coming soon.
Pro Research will introduce expanded technical context, linked evidence analysis, and comparative Company research.
Expanded product, deployment, integration, and partnership research.
Record-level provenance and review context.